Document is current
Any future updates will be listed below
-
Authors
Ledsgaard, Line
Wade, Jack
Jenkins, Timothy P.
Boddum, Kim
Oganesyan, Irina
Harrison, Julian A.
Villar, Pedro
Leah, Rachael A.
Zenobi, Renato https://orcid.org/0000-0001-5211-4358
Schoffelen, Sanne
Voldborg, Bjørn
Ljungars, Anne https://orcid.org/0000-0002-2158-0601
McCafferty, John https://orcid.org/0000-0003-2195-0972
Lomonte, Bruno https://orcid.org/0000-0003-2419-6469
Gutiérrez, José M. https://orcid.org/0000-0001-8385-3081
Laustsen, Andreas H. https://orcid.org/0000-0001-6918-5574
Karatt-Vellatt, Aneesh
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 23 January 2023
First Online: 8 February 2023
Competing interests
: The Authors declare the following competing interests: L.L., J.M.C., B.L., J.M.G., A.H.L., and A.K.V., are inventors on a patent (EP 22170880.3), jointly owned by the Technical University of Denmark, IONTAS Ltd., and the University of Costa Rica, covering the use of the antibodies described in this article. The remaining authors declare no competing interests.
